PABLO
GUISADO VASCO
PROFESOR
Hospital Severo Ochoa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Severo Ochoa (2)
2019
-
Safety and efficacy of prolonged use of dalbavancin in bone and joint infections
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5
2012
-
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series
Leukemia and Lymphoma, Vol. 53, Núm. 5, pp. 812-819